Andrew G. DuMez Memorial Lecture

The University of Maryland School of Pharmacy invites students, faculty, staff, and preceptors to attend the Andrew G. DuMez Memorial Lecture, an event that honors the legacy of Andrew G. DuMez, dean of the School of Pharmacy from 1926 to 1948.

Oct. 27, 2026
Noon-1:50 p.m.
Pharmacy Hall

Please RSVP by October 13, 2026.

What’s Next for Pharmacists: A Bitter Pill with a Spoonful of Sugar

Presented by Chan Harjivan, PharmD ‘02, MPH, MBA

Send Your RSVP

With more than 25 years of experience spanning public health, government, and the biopharmaceutical industry, Chan Harjivan, PharmD ‘02, MPH, MBA, has worked with the leadership of nearly every major pharmaceutical company, U.S. health agency, and global health organization to accelerate the development and delivery of lifesaving vaccines, therapeutics, and diagnostics.

He previously served in the White House as a special assistant, reporting directly to the president. In this role he oversaw the development and implementation of vaccines, therapeutics, diagnostics, R&D, supply chain, and response plans to strengthen the nation’s readiness for biological threats

In 2021, he co-founded SaponiQx, a next-generation vaccine adjuvant company valued at $250 million on exit. It's key product, STIMULON™ QS-21 is a potent immunostimulant, promoting both humoral and cellular immunity and is a component of several FDA-approved adjuvant systems, including GSK's Shingrix.

Harjivan was a key architect of Operation Warp Speed, the historic federal initiative that launched in 2020 to accelerate the development, manufacturing, and distribution of COVID-19 vaccines and therapeutics through unprecedented public-private collaboration and investment. It saved $1 trillion and 3 million lives.

Harjivan was previously a managing director and partner at Boston Consulting Group, where he founded and led the Public Sector Health Practice which advises governments and public-sector organizations on strategy, health care, digital transformation, technology, and organizational performance, helping leaders improve services, strengthen capabilities, and deliver measurable impact at scale. Prior to that, he was senior partner at PwC, where he founded and led the Global Health Practice.

Boxed lunches will be available post-lecture.


About Dr. Dumez

The DuMez Memorial Lecture honors Andrew G. DuMez (1885-1948), who was dean of the University of Maryland School of Pharmacy from 1926 to 1948. DuMez graduated from the University of Wisconsin, which conferred on him the degrees of PD in 1904, BS in 1907, MS in 1910, and PhD in 1917. He taught at the University of Wisconsin, Pacific University (Oregon), and the Northeastern Oklahoma Agricultural and Mechanical College. In 1912, he was appointed director of the University of Philippines School of Pharmacy, where he was instrumental in revising Philippine pharmacy and drug laws.

Returning to this country, he joined the U.S. Public Health Service as a pharmacologist. While in federal service, he served on a committee to investigate narcotics traffic in the United States and was appointed the delegate from this country to the International Conference on Drug Standardization held in Belgium.

In 1926, DuMez accepted the position of dean and professor of pharmacy at the University of Maryland School of Pharmacy. Under his administration and direction, the School continued to progress and attained a position of important leadership. He also planned and equipped a new pharmacy school building, the Pharmacy-Dental Building, which was completed in 1930.

DuMez laid the groundwork for the establishment of a graduate division, administered by the Graduate School, at the University of Maryland School of Pharmacy.

His contributions to raising the standards of pharmaceutical education were many—including his service as an officer of the American Council on Pharmaceutical Education and president of both the American Pharmaceutical Association and the American Association of Colleges of Pharmacy (AACP). He also served on AACP’s Executive Council for 20 years. He served on the Revision Committee of the U.S. Pharmacopeia for nearly three decades and was its vice chairman for 10 years.

DuMez’s eminent contributions and service earned him the highest national pharmacy award, the Remington Honor Medal from the American Pharmacists Association, in 1948.